LBPH

Longboard Pharmaceuticals Inc.

Price

return (12m)

p/e

-30.64

p/bv

8.50

DIVIDEND YIELD

0.00%

LBPH price

Longboard Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LBPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals LBPH

Valuation

P/E

-30.64

Sector 1.09

Industry -1.78

P/BV

8.50

Sector 1.86

Industry 1.35

P/Revenue (PSR)

Sector 1.55

Industry 2.25

EV/EBITDA

-72.93

Sector -47.62

Industry -42.38

EV/EBIT

-72.93

Sector -27.52

Industry -45.58

P/EBITDA

-26.75

Sector -32.64

Industry -23.10

P/EBIT

-26.75

Sector -43.02

Industry -27.18

P/Total Assets

7.88

Sector 0.87

Industry 0.82

P/Net Current Assets

8.63

Sector -27.09

Industry -72.46

P/Working Capital

8.52

Sector -4.05

Industry -2.10

EPS

-1.96

Sector -0.70

Industry -1.11

BVPS

7.06

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

0.00%

Sector 49.36%

Industry 50.48%

EBITDA Margin

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

0.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

0.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.00

Sector 0.13

Industry 0.06

Profitability

ROE

-27.74%

Sector -24.32%

Industry -33.33%

ROA

-25.71%

Sector -24.41%

Industry -45.72%

ROIC

-1,513.16%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

15.97

Sector 1.90

Industry 2.51

Net Debt / EBITDA

10.26

Sector -4.96

Industry -8.98

Net Debt / EBIT

10.26

Sector -3.08

Industry -37.38

Net Debt / Equity

-1.05

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.93

Sector 0.46

Industry 0.52

Liabilities/Assets

0.93

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

22.39%

Sector -

Industry -

Fundamentals LBPH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LBPH Longboard Pharmaceuticals Inc.	$0.00	-	0.00%	-30.64	8.50	-27.74%	0.00%
HCA HCA Healthcare Inc.	$429.56	8.26%	0.70%	12.06	-29.52	-244.72%	10.07%
FMS Fresenius Medical Care AG & Co.	$22.08	-11.22%	2.77%	10.85	0.76	7.01%	4.84%
HUM Humana Inc.	$384.07	44.95%	0.93%	35.53	2.39	6.72%	0.89%
DVA DaVita Inc.	$181.84	42.06%	0.00%	9.90	-24.44	-246.80%	8.49%
WTW Weight Watchers International, Inc	$309.74	-5.34%	1.22%	18.44	3.74	20.26%	15.58%
LH Laboratory Corporation of America Holdings	$321.66	17.70%	0.90%	26.19	3.05	11.64%	6.99%
ALHC Alignment Healthcare Inc.	$8.59	-48.53%	0.00%	43.76	6.72	15.35%	0.89%
SGRY Surgery Partners Inc.	$13.18	-39.51%	0.00%	20.73	0.55	2.64%	2.43%
LLY Eli Lilly and Compay	$1,142.35	51.23%	0.59%	38.16	30.09	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
SNY Sanofi	$42.38	-6.23%	4.17%	3.97	0.73	18.43%	14.25%
NVS Novartis AG	$139.78	16.35%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$653.75	38.92%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
GSK GlaxoSmithKline PLC	$50.03	29.66%	3.54%	15.39	4.35	28.24%	14.54%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LBPH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Longboard Pharmaceuticals

Longboard Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

6 years

Founded: 2020

2021

Time since IPO - 5 years

6

Employees

Longboard Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.34 billion, with shareholders equity totaling $275.19 million.

The company employs approximately 6 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, Longboard Pharmaceuticals Inc. reported $- in revenue, generating net income of $-76.35 million.

Key financial metrics include a P/E ratio of -30.64, a price-to-book (P/B) ratio of 8.50, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LBPH.

Market cap

$2.34 billion

Net worth

$275.19 million

$275,190,000.00

Assets

$297.00 million

$297,000,000.00

Total Shares Outstanding

39.00 million

39,000,000

Average Daily Trading Volume

$1.86 million

$1,862,067.14

Sector

Health

Industry

Health Services and Providers

LBPH

LBPH revenue and profits

Financial Results LBPH

DRAG THE FRAME TO SEE MORE DATA

LBPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35

CVS - CVS Health

$88.45 21,79% (12 M)

P/L

-0.79

3.01%

ROE

-178.93%

P/VP

1.42

CI - Cigna

$275.31 --3,58% (12 M)

P/L

10.57

1.69%

ROE

16.04%

P/VP

1.70

CNC - Centene

$65.99 107,71% (12 M)

P/L

-6.38

0.00%

ROE

-22.56%

P/VP

1.44

HUM - Humana

$384.07 54,21% (12 M)

P/L

35.53

0.93%

ROE

6.72%

P/VP

2.39

SNY - Sanofi

$42.38 --7,54% (12 M)

P/L

3.97

4.17%

ROE

18.43%

P/VP

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12 M)

P/L

38.16

0.59%

ROE

78.84%

P/VP

30.09

HCA - HCA Healthcare

$429.56 7,48% (12 M)

P/L

12.06

0.70%

ROE

-244.72%

P/VP

-29.52

NVS - Novartis

$139.78 15,92% (12 M)

P/L

20.89

2.22%

ROE

30.39%

P/VP

6.35

Frequently Asked Questions

What is the price of Longboard Pharmaceuticals (LBPH) today?

A cotação de Longboard Pharmaceuticals (LBPH) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Longboard Pharmaceuticals (LBPH) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Longboard Pharmaceuticals (LBPH) e dados de ações do Ibovespa e mercados internacionais.

Quando Longboard Pharmaceuticals (LBPH) paga dividendos?

Longboard Pharmaceuticals (LBPH) não distribuiu dividendos no último ano.

Is Longboard Pharmaceuticals (LBPH) a good investment?

Atualmente, Longboard Pharmaceuticals (LBPH) está cotada a US$ 0.00, com um P/L de -30.64, representando um desvio de -1,169% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Longboard Pharmaceuticals (LBPH) stock?

Investir em ações de Longboard Pharmaceuticals (LBPH) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Longboard Pharmaceuticals (LBPH) yield today?

A rentabilidade de Longboard Pharmaceuticals (LBPH) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Longboard Pharmaceuticals (LBPH) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LBPH

Longboard Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LBPH

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING LBPH WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Longboard Pharmaceuticals

Longboard Pharmaceuticals Inc.

United States

6 years

2021

6

PROFIT X PRICE LBPH

Financial Results LBPH

LBPH cash flow

Asset, Revenue and Profit Growth - LBPH

LBPH balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions